Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AimVion A/S
A/S
In liquidation
Advertising protection
CVR 37120618
Søndergade 74, 8000
Aarhus C
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2015 · 10 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
AimVion A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (3)
HH
Hans Henrik Højrup Bondegaard
Unofficial title
Unofficial title
2022 – 2023
SB
Shervin Bahrami
Management
Management
2015 – 2020
CG
Christian Gunni Pedersen
Management
Management
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
JL
Jørgen Lillelund Olsen
Chairman
Chairman
2015 – 2015
PS
Peter Samuel Wulff
Chairman
Chairman
2019 – 2019
NJ
Niels Jonas Heilskov Graversen
Board of Directors
Board of Directors
2015 – 2016
UU
Uffe Uhrenholt
Board of Directors
Board of Directors
2016 – 2022
HD
Hanne Damgaard Jensen
Chairman
Chairman
2019 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
TANDLÆGE PETER KOHBERG HOLDING ApS
Company
5–9.99%
5–9.99%
2016
Kristian Stengaard-Pedersen
Individual
5–9.99%
5–9.99%
2015
ORMAZD HOLDING ApS
Company
15–19.99%
15–19.99%
2015
Michael Kanstrup-Pedersen
Individual
15–19.99%
15–19.99%
2015
FAURSKOV GODS A/S
Company
15–19.99%
15–19.99%
2015
Anne Margrethe Troldborg
Individual
5–9.99%
5–9.99%
2015
Lars Allan Thomassen
Individual
10–14.99%
10–14.99%
2020
Sleeping Beauty ApS
Company
10–14.99%
10–14.99%
2019
PHIDEAS ApS
Company
5–9.99%
5–9.99%
2015
Jens Thygesen
Individual
5–9.99%
5–9.99%
2015
Laska Holding ApS
Company
5–9.99%
5–9.99%
2015
Masoud Mojaza
Individual
15–19.99%
15–19.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AimVion A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network